Aristotle University Of Thessaloniki (AUTH)
Συσχέτιση της ιστοσυμβατότητας μέσω των προσχηματισμένων και των de novo ειδικών για το δότη αντι - HLA αντισωμάτων στην έκβαση της μεταμόσχευσης ήπατος
Abstract
dc:descriptionThe major histocompatibility complex MHC antigens, are the expression of a set of closely related and highly polymorphic genes, found in all vertebrates. Their role in the immune response and the distinction between foreign and self antigens is extremely important. Many efforts have been made to demonstrate their role and their impact on liver transplants, during recent years. At present, the results are controversial, mainly because of liver’s immune tolerance. In the present study, the role of pre-formed and de novo anti-HLA DSAs in the immune rejection of liver graft, was investigated. The risk factors causing the appearance of DSAs, resulting in allograft dysfunction and the occurrence of rejection events, were also investigated. Material-Methods: In a total of 65 patients who underwent liver transplantation, testing for the presence of anti-HLA antibodies was performed with Luminex screening and then patients with positive results, were tested for anti-HLA-A, B, C class I and anti-HLA-DR, DQ, DP class II IgG antibodies. Testing was carried out before transplantation, 1, 3, 6 and 12 months after transplantation and yearly thereafter. The presence of specific risk factors was also studied: recipient and donor age, time at waiting list, cold ischemia time (CIT) at transplantation, cytomegalovirus (CMV) infection pre- and post-transplantation, mTORi (Mammalian target of rapamycin inhibitors) immunosuppression and its effects, Model for End-Stage Liver Disease (MELD) transplantation score, aspartate transaminase (AST), alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) values before and after transplantation, and alanine transaminase (ALT), direct bilirubin (DBIL) and total bilirubin (TBIL) values after transplantation. Results: The results of the study of pre-formed anti-HLA antibodies showed that: 16 out of 65 patients (24.6%) had already pre-formed anti-HLA antibodies. Four of them (25%) had preformed DSAs. One out of 4 patients (25%) with preformed DSAs of both class I and II maintained them after transplantation. All four patients (100%) had allograft dysfunction, 2 (50%) ductopenia and the other 2 (50%) biliary strictures. The results of the study of de novo anti-HLA antibodies showed that: fourteen out of 65 patients (21.5%) presented de novo DSA, whereas eleven out of 65 (17.2%) presented de novo anti-HLA antibodies, but not DSAs. The total number of de novo DSAs detected was 20 and 18 of them (90%) were in class II. Two of them (10%) were in class I and 18 of them (90%) in class II. Eight out of 18 (44.4%) de novo class II DSAs were DQ and all patients (100%) showed allograft dysfunction. In addition, all patients with de novo class I DSA (100%) also exhibited allograft dysfunction. The mean MFIs for de novo class I and IIDSAs was < 5000. In particular, for DQ the average MFIs were 6499 (1048 - 21205). Conclusion: Finally, multivariable analysis demonstrated that de novo DSAs and time at waiting list are independent risk factors for allograft dysfunction and rejection events.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papachristou, Marianthi
- Παπαχρήστου, Μαριάνθη
Subjects
dc:subject × 12- Ιστοσυμβατότητα
- Προσχηματισμένα αντι HLA αντισώματα
- De novo αντι HLA αντισώματα
- Έκβαση μεταμόσχευσης ήπατος
- Histocompatibility
- Preformed anti - HLA antibody
- De novo anti - HLA antibody
- Outcome of liver transplantation
- Ιατρική και Επιστήμες Υγείας
- Άλλες Ιατρικές Επιστήμες
- Medical and Health Sciences
- Other Medical Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45435